RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma

RFWD2, an E3 ubiquitin ligase, is overexpressed in numerous human cancers, including leukemia, lung cancer, breast cancer, renal cell carcinoma, and colorectal cancer. The roles of RFWD2 in cancer are related to the targeting of its substrates for ubiquitination and degradation. This study aimed to...

Full description

Bibliographic Details
Main Authors: Ruimin Hao, Jinxia Hu, Yuemei Liu, Dongmin Liang, Yan-Mei Li, Ranran Wang, Shucui Zhang, Pingyu Wang, You-Jie Li, Shuyang Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.733175/full
_version_ 1818436567643979776
author Ruimin Hao
Jinxia Hu
Yuemei Liu
Dongmin Liang
Yan-Mei Li
Ranran Wang
Shucui Zhang
Pingyu Wang
You-Jie Li
Shuyang Xie
author_facet Ruimin Hao
Jinxia Hu
Yuemei Liu
Dongmin Liang
Yan-Mei Li
Ranran Wang
Shucui Zhang
Pingyu Wang
You-Jie Li
Shuyang Xie
author_sort Ruimin Hao
collection DOAJ
description RFWD2, an E3 ubiquitin ligase, is overexpressed in numerous human cancers, including leukemia, lung cancer, breast cancer, renal cell carcinoma, and colorectal cancer. The roles of RFWD2 in cancer are related to the targeting of its substrates for ubiquitination and degradation. This study aimed to investigate the role of TRIB2 in relation to the regulation of protein degradation through RFWD2. inBio Discover™ results demonstrated that TRIB2 can perform its functions by interacting with RFWD2 or other factors. TRIB2 can interact with and regulate RFWD2, which further attends the proteasome-mediated degradation of the RFWD2 substrate p-IκB-α. TRIB2 colocalizes with RFWD2-related IκB-α to form a ternary complex and further affects the IκB-α degradation by regulating its phosphorylation. Specific domain analysis showed that TRIB2 may bind to RFWD2 via its C-terminus, whereas it binds to IκB via its pseudokinase domain. TRIB2 acts as an oncogene and promotes cancer cell proliferation and migration, whereas RFWD2 knockdown reversed the role of TRIB2 in promoting cancer cell growth and colony formation in vitro and in vivo. In summary, this study reveals that TRIB2 promotes the progression of cancer by affecting the proteasome-mediated degradation of proteins through the interaction with RFWD2.
first_indexed 2024-12-14T17:10:50Z
format Article
id doaj.art-5a4924d4495c4236a09a8a3999a33f78
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-14T17:10:50Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-5a4924d4495c4236a09a8a3999a33f782022-12-21T22:53:35ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.733175733175RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung AdenocarcinomaRuimin Hao0Jinxia Hu1Yuemei Liu2Dongmin Liang3Yan-Mei Li4Ranran Wang5Shucui Zhang6Pingyu Wang7You-Jie Li8Shuyang Xie9Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Immune Rheumatism, Yantaishan Hospital, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaKey Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaDepartment of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai, ChinaRFWD2, an E3 ubiquitin ligase, is overexpressed in numerous human cancers, including leukemia, lung cancer, breast cancer, renal cell carcinoma, and colorectal cancer. The roles of RFWD2 in cancer are related to the targeting of its substrates for ubiquitination and degradation. This study aimed to investigate the role of TRIB2 in relation to the regulation of protein degradation through RFWD2. inBio Discover™ results demonstrated that TRIB2 can perform its functions by interacting with RFWD2 or other factors. TRIB2 can interact with and regulate RFWD2, which further attends the proteasome-mediated degradation of the RFWD2 substrate p-IκB-α. TRIB2 colocalizes with RFWD2-related IκB-α to form a ternary complex and further affects the IκB-α degradation by regulating its phosphorylation. Specific domain analysis showed that TRIB2 may bind to RFWD2 via its C-terminus, whereas it binds to IκB via its pseudokinase domain. TRIB2 acts as an oncogene and promotes cancer cell proliferation and migration, whereas RFWD2 knockdown reversed the role of TRIB2 in promoting cancer cell growth and colony formation in vitro and in vivo. In summary, this study reveals that TRIB2 promotes the progression of cancer by affecting the proteasome-mediated degradation of proteins through the interaction with RFWD2.https://www.frontiersin.org/articles/10.3389/fonc.2021.733175/fullRFWD2proteasome-mediated degradationTRIB2cancer therapytarget gene
spellingShingle Ruimin Hao
Jinxia Hu
Yuemei Liu
Dongmin Liang
Yan-Mei Li
Ranran Wang
Shucui Zhang
Pingyu Wang
You-Jie Li
Shuyang Xie
RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
Frontiers in Oncology
RFWD2
proteasome-mediated degradation
TRIB2
cancer therapy
target gene
title RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
title_full RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
title_fullStr RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
title_full_unstemmed RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
title_short RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
title_sort rfwd2 knockdown as a blocker to reverse the oncogenic role of trib2 in lung adenocarcinoma
topic RFWD2
proteasome-mediated degradation
TRIB2
cancer therapy
target gene
url https://www.frontiersin.org/articles/10.3389/fonc.2021.733175/full
work_keys_str_mv AT ruiminhao rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT jinxiahu rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT yuemeiliu rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT dongminliang rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT yanmeili rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT ranranwang rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT shucuizhang rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT pingyuwang rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT youjieli rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma
AT shuyangxie rfwd2knockdownasablockertoreversetheoncogenicroleoftrib2inlungadenocarcinoma